Next-Generation Sequencing (NGS)

Transforming genomics and beyond 

Next-Generation Sequencing (NGS) is a powerful DNA sequencing technology that determines the order of nucleotides in entire genomes or specific regions of DNA or RNA. As a groundbreaking advancement in genomics, NGS has revolutionized the way we study and understand genetic information. 

In the rapidly evolving fields of genomics and bioinformatics, NGS enables researchers to decode genetic material at unprecedented speed and scale, paving the way for innovative discoveries. Tasks like sequencing a human genome, which once took years, can now be completed in days or weeks. 

The high-throughput capabilities of NGS are a game-changer across various sectors, including research, clinical applications, biopharma, and pharmaceuticals. Over the past two decades, NGS has made significant contributions to genomic research, disease diagnostics, personalized medicine, cancer genomics, vaccine development, agriculture and ecology, microbiome studies, and food safety.  

The EMA and FDA have recognized the critical importance of NGS in the biopharma and pharmaceutical industries. At Eurofins Biopharma Product Testing Denmark, we are at the forefront of NGS testing, following FDA and EMA guidelines to ensure compliance with GMP regulations. Our protocols and expertise make us a leader in NGS testing and bioinformatics.  

Our testing portfolio includes: 

• GMP Testing for Microbiome and Live Biotherapeutic Products 
• DNA/RNA Vaccines 
• Cell Characteristics Studies 
• Raw Material Testing 
• Adventitious Virus Detection 
• Bioinformatics Services 

And more coming soon! 

Want to learn more about Next-Generation Sequencing and how it can benefit you? Then press the contact button.